A Randomized, Double-Blind, Placebo-Controlled Multicenter Phase III Trial of Alpha 1 ? Antitrypsin AAT Combined with Corticosteroids vs Corticosteroids Alone for the Treatment of High Risk Acute Graft-versus-Host Disease GVHD Following Allogeneic Hematopoietic Stem Cell Transplant

Brief Summary

Type:
Hematologic - Other

Study Type:
Treatment

Phase:
III

ClinicalTrials.gov Identifier:
NCT04167514

Study #:
STUDY00144792

Start Date:
Jul 14, 2022

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT04167514

View Complete Trial Details & Eligibility at ClinicalTrials.gov